Indivior PLC
OTC: INVVY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mark Crossley
- Employees
- 1,000
- Headquarters
- North Chesterfield, United States
- IPO year
- 2015
- Market cap
- $3.0B
- Website
- https://www.indivior.com
Loading INVVY…
Loading profile data…Frequently asked questions about INVVY
What does Indivior PLC (INVVY) do?
Indivior PLC, encompassing its various subsidiaries, is a pharmaceutical firm dedicated to the research, production, and global commercialization of prescription medications. These therapies primarily utilize buprenorphine to treat opioid dependence and associated medical conditions. The company's development pipeline is actively exploring novel...
Where does INVVY trade?
Indivior PLC (INVVY) trades on the Other OTC.
What sector is INVVY in?
Indivior PLC (INVVY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Indivior PLC?
Mark Crossley is the chief executive officer of Indivior PLC (INVVY).
Where is Indivior PLC headquartered?
Indivior PLC is headquartered in United States.
Does INVVY pay a dividend?
Yes — Indivior PLC (INVVY) paid a trailing twelve-month dividend of USD 0.64 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did INVVY go public?
Indivior PLC (INVVY) completed its initial public offering in 2015.
Is INVVY an ADR?
Yes — INVVY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Indivior PLC reporting and dividends follow the underlying issuer.